A parallel-group treatment, proof-of-concept Phase 2, multicenter, double blind, randomized two arm clinical trial to investigat

A parallel-group treatment, proof-of-concept Phase 2, multicenter, double blind, randomized two arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate to severe chronic peripheral neuropathic pain due to postherpetic neuralgia or peripheral nerve injury.

Abierta

Código protocolo: M602011079
Código EudraCT: No aplica
Grupo de investigación: Farmacología Clínica
Servicio: Anestesia
Investigador/a principal: Medel Rebollo, Francisco Javier
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase II